Brokerages Set Soleno Therapeutics, Inc. (NASDAQ:SLNO) PT at $104.67
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has been assigned an average rating of “Buy” from the ten brokerages that are presently covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12 month price […]
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has been assigned an average rating of “Buy” from the ten brokerages that are presently covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12 month price […]
